13 hours Apellis Pharmaceuticals, Inc. (NASDAQ:APLS) Receives Consensus Rating of “Moderate Buy” from Analysts MarketBeat
Shares of Apellis Pharmaceuticals, Inc. (NASDAQ:APLS – Get Free Report) have received a consensus rating of “Moderate Buy” from the fifteen analysts that are presently covering the firm, MarketBeat.com reports. Four investment analysts have rated the …